Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?


Drug Profile


Alternative Names: EFAPROXYN; GSJ 61; JP 4; KDD 86; REVAPROXYN; RS 4; RSR 13

Latest Information Update: 25 Jun 2007

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Center for Innovative Technology
  • Developer Allos Therapeutics
  • Class Aniline compounds; Antineoplastics; Propionic acids; Radiosensitisers; Small molecules
  • Mechanism of Action Haemoglobin modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Brain cancer

Highest Development Phases

  • Discontinued Angina pectoris; Brain cancer; Cervical cancer; Glioblastoma; Glioma; Myocardial infarction; Non-small cell lung cancer; Stroke

Most Recent Events

  • 24 Jun 2018 Biomarkers information updated
  • 19 Jun 2007 Discontinued - Phase-I/II for Cervical cancer in Canada (IV)
  • 19 Jun 2007 Discontinued - Phase-I/II for Glioma in USA (IV)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top